(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202509 | 202409 | % Var | 202509 | 202409 | % Var | 202503 | 202403 | % Var | |
| Sales | 26087.80 | 25441.80 | 2.54 | 51501.40 | 49568.00 | 3.90 | 94978.00 | 86292.50 | 10.07 |
| Other Income | 776.70 | 1074.80 | -27.74 | 1418.90 | 2035.20 | -30.28 | 4932.10 | 2705.00 | 82.33 |
| PBIDT | 7708.60 | 8709.70 | -11.49 | 15081.50 | 15430.50 | -2.26 | 30557.60 | 25367.90 | 20.46 |
| Interest | 1472.00 | 26.10 | 5539.85 | 2939.00 | 92.40 | 3080.74 | 3717.60 | 163.30 | 2176.55 |
| PBDT | 6236.60 | 8683.60 | -28.18 | 12142.50 | 15338.10 | -20.83 | 26840.00 | 25204.60 | 6.49 |
| Depreciation | 990.30 | 903.30 | 9.63 | 1959.60 | 1816.60 | 7.87 | 3780.10 | 3352.60 | 12.75 |
| PBT | 5246.30 | 7780.30 | -32.57 | 10182.90 | 13521.50 | -24.69 | 23059.90 | 21852.00 | 5.53 |
| TAX | 657.30 | 1646.80 | -60.09 | 1466.30 | 2623.80 | -44.12 | 4217.40 | 4125.70 | 2.22 |
| Deferred Tax | -318.10 | 322.60 | -198.61 | -430.50 | 213.70 | -301.45 | -481.90 | 12.40 | -3986.29 |
| PAT | 4589.00 | 6133.50 | -25.18 | 8716.60 | 10897.70 | -20.01 | 18842.50 | 17726.30 | 6.30 |
| Equity | 412.80 | 400.60 | 3.05 | 412.80 | 400.60 | 3.05 | 412.60 | 400.60 | 3.00 |
| PBIDTM(%) | 29.55 | 34.23 | -13.69 | 29.28 | 31.13 | -5.93 | 32.17 | 29.40 | 9.44 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1654.70 |
| Dr. Reddys Lab | 1232.00 |
| Cipla | 1229.60 |
| Zydus Lifesciences | 915.45 |
| Lupin | 2332.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: